Cholesterol‐derivatized polyurethane: Characterization and endothelial cell adhesion
- 9 December 2004
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 72A (2) , 200-212
- https://doi.org/10.1002/jbm.a.30224
Abstract
Endothelialization of synthetic surfaces has been challenging with limited success thus far. We investigated the hypothesis that covalent attachment of cholesterol to polyurethane via the urethane nitrogen groups would create a high-affinity surface for attachment and adhesion of endothelial cells. Cholesterol was covalently bound to the polyether polyurethane, Tecothane®, by first derivatizing the polyurethane nitrogen groups with bromoalkyl side chains, followed by reacting mercapto-cholesterol to the bromoalkyl sites. Cholesterol-modified polyurethane demonstrated a qualitatively smoother surface per atomic force microscopy than nonmodified and increased surface energy (contact angle measurements) compared with unmodified polyurethane. Cell attachment assays showed a significantly greater number of attached bovine arterial endothelial cells (p = 0.0003) after 45 min of seeding on cholesterol-modified polyurethane versus unmodified polyurethane. Bovine arterial endothelial cells cultivated on cholesterol-modified Tecothane® showed significantly greater levels of cell retention compared with unmodified Tecothane® when exposed to arterial level shear stress for 2 h (25 dynes/cm2) with 90.0 ± 6.23% cells remaining adherent compared with unmodified polyurethane, 41.4 ± 11.7%, p = 0.0070. Furthermore, ovine endothelial precursors, obtained as blood outgrowth endothelial cells, were seeded on cholesterol-modified polyurethane and exposed to 25 dynes/cm2 shear conditions for 2 h, with the retention of 90.30 ± 3.25% of seeded cells versus unmodified polyurethane, which retained only 4.56 ± 0.85% (p < 0.001). It is concluded that covalently linking cholesterol to polyurethane results in improved material properties that permit increased endothelial cell retention compared with unmodified polyurethane. © 2004 Wiley Periodicals, Inc. J Biomed Mater Res 72A: 200–212, 2005Keywords
This publication has 27 references indexed in Scilit:
- Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implantsGene Therapy, 2003
- Engineering porous polyurethane scaffolds by photografting polymerization of methacrylic acid for improved endothelial cell compatibilityJournal of Biomedical Materials Research Part A, 2003
- Prevention of polyurethane valve cusp calcification with covalently attached bisphosphonate diethylamino moietiesJournal of Biomedical Materials Research, 2003
- Quantitative Evaluation of Endothelial Progenitors and Cardiac Valve Endothelial Cells: Proliferation and Differentiation on Poly-glycolic acid/Poly-4-hydroxybutyrate Scaffold in Response to Vascular Endothelial Growth Factor and Transforming Growth Factor β1Tissue Engineering, 2003
- Adhesion and growth of endothelial cell on amphiphilic PU/PS IPN surface: Effect of amphiphilic balance and immobilized collagenJournal of Biomedical Materials Research, 2002
- Elastomeric polyurethanes modified with geminal bisphosphonate groupsJournal of Polymer Science Part A: Polymer Chemistry, 2000
- Origins of circulating endothelial cells and endothelial outgrowth from bloodJournal of Clinical Investigation, 2000
- Totally implantable artificial hearts and left ventricular assist devices: Selecting impermeable polycarbonate urethane to manufacture ventriclesJournal of Biomedical Materials Research, 1999
- Synthesis and blood compatibility evaluation of segmented polyurethanes based on cholesterol and phosphatidylcholine analogous moietiesBiomaterials, 1996
- Synthesis and characterization of polyurethanes containing cholesterol and phosphatidylcholine analogous moietiesMacromolecular Rapid Communications, 1995